Akero Therapeutics AKRO
$ 31.4
-2.03%
Quarterly report 2024-Q2
added 08-09-2024
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Andrew Cheng |
Employees in the company |
16 |
Shares |
52.6 M |
Market Cap[1] |
$ 1.65 B |
EBITDA (LTM) |
$ -115 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.